Helping you make wiser investment decisions

J&J tracks the path to a COVID-19 vaccine in new online news series

April 14, 2020 Beth Snyder

What will it take to develop a vaccine for COVID-19? Johnson & Johnson is taking viewers behind the scenes with an original online video series. Beginning Tuesday, producer and journalist Lisa Ling will host a program titled, “The Road to a Vaccine.” Each 30-minute show will air live online on Tuesdays on Facebook, Twitter, LinkedIn and

Over the next eight weeks, Ling will interview experts from J&J, including chief scientific officer Paul Stoffels, along with public health experts, scientists and frontline healthcare workers. The show will cover the behind-the-scenes scientific efforts in the lab—how a vaccine is being made and what can be expected—as well as efforts to end the outbreak from public health and local community personnel around the world.

RELATED: J&J, BARDA commit $1B to COVID-19 vaccine R&D

Free Amazon Webinar

Performing end to end real-world evidence generation in the cloud with traceability and transparency- a Sanofi journey

In this webinar you will hear about Sanofi’s journey and experience in building an industrialized big data & analytics platform in the cloud that handles billions of rows of RWD data with complete data traceability, security, and supports both traditional and advanced analytics for day to day evidence generation (RWE).

J&J recently unveiled a lead COVID-19 vaccine candidate along with a $1 billion commitment in partnership with the U.S. Biomedical Advanced Research and Development Authority (BARDA) to develop it. The company plans to have a vaccine in clinical trials by September, win emergency use by early next year and add manufacturing capacity to produce more than one billion doses.

J&J is one of several drugmakers, including Moderna, Inovio, Pfizer and Sanofi, that are advancing COVID-19 candidates. Experts say it’s possible that multiple vaccines against COVID-19 could be available on a limited basis by this time next year.

RELATED: Pfizer’s chief medical officer talks COVID-19 on social media

The World Health Organization Monday announced its coordination of an international group of more than 120 scientists, physicians, public health and manufacturing experts—including those from J&J, Sanofi, Altimmune, Moderna, Inovio and CureVac—to help speed the availability of a vaccine for COVID-19.

Source link